Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose

Dasatinib increases endothelial permeability leading to pleural effusion

(2018) Carole Phan et al.   EUROPEAN RESPIRATORY JOURNAL

Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia

(2018) Timothy P. Hughes et al.   HAEMATOLOGICA

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

(2018) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study

(2017) Jason Weatherald et al.   EUROPEAN RESPIRATORY JOURNAL

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib

(2017) Karan Seegobin et al.   Pulmonary Circulation

First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response – systematic review and meta-analysis

(2016) Ronit Gurion et al.   ACTA ONCOLOGICA

Pulmonary hypertension associated with ponatinib therapy: TABLE 1

(2016) Fleur-Marie Quilot et al.   EUROPEAN RESPIRATORY JOURNAL

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

(2016) Christophe Guignabert et al.   JOURNAL OF CLINICAL INVESTIGATION

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

(2016) Jorge E. Cortes et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib

(2015) Neil P. Shah et al.   AMERICAN JOURNAL OF HEMATOLOGY

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

(2015) L Kalmanti et al.   LEUKEMIA

Ponatinib

(2014) Caitlin L. Shamroe et al.   ANNALS OF PHARMACOTHERAPY

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

(2014) Ji Hyung Hong et al.   Cancer Research and Treatment

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

(2012) David Montani et al.   CIRCULATION